Theranos halts new Zika test

|About: Theranos (THERA)|By:, SA News Editor

In yet another setback for Theranos (Private:THERA), the company withdrew its request for emergency clearance of a Zika-virus blood test after federal regulators found it didn't include proper patient safeguards, WSJ reports.

Meanwhile, Singapore has confirmed another 26 locally-transmitted Zika cases, bringing the total to 82, with some new victims being identified outside of the previously-affected areas.

Subscribe for full text news in your inbox